Featured Research

from universities, journals, and other organizations

New Model Of Prostate Cancer Helps Identify Promising Pain Treatment

Date:
December 2, 2005
Source:
Ohio State University
Summary:
Researchers have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease. This new cancer-cell line has already provided some help. One new study in mice identified a promising possible therapy to reduce skeletal pain that accompanies prostate cancer. Scientists found that a substance called anti-nerve growth factor appeared to be more effective in controlling pain in mice than even morphine.

Researchers have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease.

This new cancer-cell line has already provided some help. One new study in mice identified a promising possible therapy to reduce skeletal pain that accompanies prostate cancer. Scientists found that a substance called anti-nerve growth factor appeared to be more effective in controlling pain in mice than even morphine.

But the work would not have been possible without the new cell line, said Tom Rosol , a study co-author and a professor of veterinary medicine at Ohio State University.

Armed with this new cell line, scientists will be able to more directly study how prostate cancer affects the body, said Rosol, whose laboratory developed the cell line.

Metastatic bone tumors are a common manifestation in patients with late-stage breast cancer or prostate cancer. “Metastasis” means that cancer has spread from its original site to other areas of the body. But breast cancer typically destroys bone at tumor sites, whereas prostate cancer tumors that spread to bone induce abnormal bone growth.

Currently, most models used to study prostate cancer do not mimic the human condition and the resulting bone metastases. Most of these models really mimic the spread of breast cancer since the bone metastases in that disease are associated with bone loss rather than bone growth.

“Even though there is more bone at the sites of prostate cancer tumors, this formation still damages the bone,” said Rosol, who is also dean of the College of Veterinary Medicine at Ohio State . “The new growth compresses nerves, making it terribly painful for the patient.”

The results appear in a recent issue of the journal Cancer Research. The study was led by Patrick Mantyh, a professor of preventive sciences at the University of Minnesota.

Only two mammals are known to develop prostate cancer –- men and dogs. Rosol's laboratory created a cell line from prostate tumors that had developed in a dog's bones. The researchers call this line of cells ACE-1.

In the current study, researchers at the University of Minnesota injected the ACE-1 cells directly into the femurs, or thigh bones, of male mice. These mice were specially bred to lack an immune system, leaving them vulnerable to developing prostate cancer. While the femur is the biggest bone in the body -- and therefore the easiest to study in this case -- prostate cancer can affect any bone in the body.

It took about a week for the prostate tumors to develop in the mice. At that point, the researchers began treating mice with anti-nerve growth factor (NGF). Anti-NGF is a molecule that naturally occurs in the body, where it promotes the survival and growth of nerves. An additional group of mice was treated with morphine. Control mice, which also had prostate cancer, were given a sterile saline solution instead of either anti-NGF or morphine.

The researchers wanted to know what kind of effect, if any, anti-NGF had on pain-related behaviors, tumor growth, bone formation and bone destruction in the mice.

The researchers watched mice at different points in the study to see if they showed any kind of pain-related behavior. The researchers kept track of how much time each mouse spent favoring its affected leg – how often the mouse lifted its leg while standing still, and for how long it held this leg aloft.

Mice treated with anti-NGF spent less time favoring their affected leg than did mice that were given morphine. In some cases, the time that a mouse treated with anti-NGF spent favoring its affected leg was half that of a mouse treated with morphine.

This suggests that anti-NGF therapy may be effective in reducing pain, thereby helping to enhance the quality of life in patients with bone pain caused by prostate cancer.

All of the animals were euthanized about two weeks after receiving the first round of ACE-1 injections. At that point, the researchers removed the affected thigh bone from each mouse in order to analyze the bone's density. Bone density corresponded with the number of tumors in the bone – the denser the bone, the more tumors it had.

Results from the density analysis showed that anti-NGF therapy did not stop prostate cancer from progressing, nor did it decrease bone formation caused by the disease.

Why prostate cancer causes excess bone to form remains a mystery, but having the ACE-1 model may help researchers learn why it happens.

“Bone is often the only clinically detectable site of the spread of prostate cancer,” Rosol said. “Understanding why this happens is not only important for cancer patients, but also for scientists who are trying to understand how bone responds to different biochemical factors.”

Rosol conducted the study with researchers from the University of Minnesota; the Veterans Affairs Medical Center in Minneapolis; and with Rinat Neuroscience Corporation, in Palo Alto, Calif.

This work was supported by a grant from the National Institutes of Health, the MinCREST program at the University of Minnesota and a Merit Review from the Veterans Administration.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "New Model Of Prostate Cancer Helps Identify Promising Pain Treatment." ScienceDaily. ScienceDaily, 2 December 2005. <www.sciencedaily.com/releases/2005/12/051202092934.htm>.
Ohio State University. (2005, December 2). New Model Of Prostate Cancer Helps Identify Promising Pain Treatment. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2005/12/051202092934.htm
Ohio State University. "New Model Of Prostate Cancer Helps Identify Promising Pain Treatment." ScienceDaily. www.sciencedaily.com/releases/2005/12/051202092934.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins